These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 9609085)

  • 1. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Yandle TG; Frampton C; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Ikram H; Crozier IG; Smyth DW
    Circulation; 1998 May; 97(19):1921-9. PubMed ID: 9609085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.
    Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW
    Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton C; Turner J; Crozier IG; Yandle TG
    Circulation; 2003 Jun; 107(22):2786-92. PubMed ID: 12771003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group.
    Richards AM; Doughty R; Nicholls MG; MacMahon S; Sharpe N; Murphy J; Espiner EA; Frampton C; Yandle TG;
    J Am Coll Cardiol; 2001 Jun; 37(7):1781-7. PubMed ID: 11401111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.
    Motwani JG; McAlpine H; Kennedy N; Struthers AD
    Lancet; 1993 May; 341(8853):1109-13. PubMed ID: 8097802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.
    Choy AM; Darbar D; Lang CC; Pringle TH; McNeill GP; Kennedy NS; Struthers AD
    Br Heart J; 1994 Jul; 72(1):16-22. PubMed ID: 7741839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction.
    Nagaya N; Nishikimi T; Goto Y; Miyao Y; Kobayashi Y; Morii I; Daikoku S; Matsumoto T; Miyazaki S; Matsuoka H; Takishita S; Kangawa K; Matsuo H; Nonogi H
    Am Heart J; 1998 Jan; 135(1):21-8. PubMed ID: 9453517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators.
    Daggubati S; Parks JR; Overton RM; Cintron G; Schocken DD; Vesely DL
    Cardiovasc Res; 1997 Nov; 36(2):246-55. PubMed ID: 9463636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurohormones in an ovine model of compensated postinfarction left ventricular dysfunction.
    Rademaker MT; Cameron VA; Charles CJ; Espiner EA; Nicholls MG; Pemberton CJ; Richards AM
    Am J Physiol Heart Circ Physiol; 2000 Mar; 278(3):H731-40. PubMed ID: 10710340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmented secretion of atrial and brain natriuretic peptides during dynamic exercise in patients with old myocardial infarction.
    Marumoto K; Hamada M; Aburaya M; Hiwada K
    Jpn Circ J; 1995 Nov; 59(11):715-24. PubMed ID: 8747761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of exercise on plasma adrenomedullin and natriuretic peptide levels in myocardial infarction.
    Morimoto A; Nishikimi T; Takaki H; Okano Y; Matsuoka H; Takishita S; Kitamura K; Miyata A; Kangawa K; Matsuo H
    Clin Exp Pharmacol Physiol; 1997 May; 24(5):315-20. PubMed ID: 9143780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
    Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
    J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.
    Davidson NC; Naas AA; Hanson JK; Kennedy NS; Coutie WJ; Struthers AD
    Am J Cardiol; 1996 Apr; 77(10):828-31. PubMed ID: 8623734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
    Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac natriuretic peptides after myocardial infarction: relationship with infarct size, left ventricular function and remodelling assessed by 99mTc-sestamibi gated-single photon emission tomography.
    Ceriani L; Giovanella L
    Clin Chem Lab Med; 2007; 45(2):226-31. PubMed ID: 17311513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction.
    Arakawa N; Nakamura M; Aoki H; Hiramori K
    J Am Coll Cardiol; 1996 Jun; 27(7):1656-61. PubMed ID: 8636550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction.
    Friedl W; Mair J; Thomas S; Pichler M; Puschendorf B
    Heart; 1996 Aug; 76(2):129-36. PubMed ID: 8795474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.